PMID: 7542008Mar 1, 1995Paper

Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage

Biological Chemistry Hoppe-Seyler
K D KrönckeV Kolb-Bachofen

Abstract

The N-methyl-N-nitroso-urea streptozotocin is an antibiotic with diabetogenic, carcinogenic and antitumor activity thought to act via alkylation of DNA and proteins. Evidence points to a release of bioactive nitric oxide (NO) from streptozotocin as an additional cytotoxic activity of this drug. Here we show by EPR spectroscopy, that NO is not generated during spontaneous decay of streptozotocin but that its metabolization in rat hepatocytes and pancreatic islet cells yields NO. This NO formation is not due to a NO synthase (NOS) activity since NO formation in hepatocytes in the presence of streptozotocin is not blocked by the NOS inhibitor NG-methyl-L-arginine. By iNOS-specific RT-PCR no positive signal for specific mRNA presence was obtained in streptozotocin-treated cells, proving that iNOS activity was not induced during cell isolation procedures and did not account for the NO release. Furthermore, early DNA-strand breaks induced either by SZ or by the NO donor nitroprusside were both significantly reduced in the presence of an intracellular NO scavenger. In contrast, DNA damage found after incubation with the purely alkylating agent methylmethanesulfonate was not inhibited by the NO trap. These results prove that intracellu...Continue Reading

References

Sep 1, 1978·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·D L Vesely, G S Levey
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C J LowensteinS H Snyder
Mar 29, 1991·Biochemical and Biophysical Research Communications·K D KrönckeH Kolb
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J R Lancaster, J B Hibbs
Jul 16, 1990·Biochemical and Biophysical Research Communications·K S WoodL J Ignarro
Feb 28, 1989·European Journal of Pharmacology·G Thomas, P W Ramwell
Aug 30, 1967·Journal of the American Chemical Society·R R HerrA D Argoudelis
Jan 1, 1981·Methods in Enzymology·E E Di Iorio
Mar 15, 1980·The Biochemical Journal·J Schlepper-SchäferH Kolb
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroR E Byrns
May 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N S KwonH S Lee
Mar 15, 1993·Biochemical and Biophysical Research Communications·K C ChangP S Park

❮ Previous
Next ❯

Citations

Jan 7, 2000·Biochemical and Biophysical Research Communications·R J KonradJ E Kudlow
Jan 6, 2007·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Manisha A ModakSaroj S Ghaskadbi
Dec 1, 2010·Bulletin of Experimental Biology and Medicine·V B PisarevA E Bulanov
Jan 2, 2007·Biochemical and Biophysical Research Communications·Elena N Fazio, Christopher L Pin
Mar 23, 1999·Biochemical Pharmacology·M MurataS Kawanishi
Jul 31, 1998·European Journal of Pharmacology·C Szabó
Nov 25, 2000·Toxicology·E Adeghate, S H Parvez
Apr 18, 2000·Mutation Research·M MasutaniT Sugimura
Dec 5, 2002·Mutation Research·Alejandro D Bolzán, Martha S Bianchi
Aug 26, 1998·Clinical and Experimental Immunology·K D KrönckeV Kolb-Bachofen
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·K LiuJ E Kudlow
Oct 15, 2013·The American Journal of Chinese Medicine·Hyo-Jin LeeYoung-Chae Chang
Jun 8, 2011·Clinical & Developmental Immunology·Meghan M Delmastro, Jon D Piganelli
Jan 1, 2011·African Journal of Traditional, Complementary, and Alternative Medicines : AJTCAM·Stephen O AdewoleJohn A O Ojewole
Mar 28, 2006·Future Oncology·Alena Pance
Feb 1, 1996·Free Radical Research·K D Kröncke, V Kolb-Bachofen
Dec 23, 2009·FEBS Letters·Helge C Dorfmueller, Daan M F van Aalten
Feb 1, 1997·Drug Metabolism Reviews·P Moffatt, F Denizeau
Jul 19, 2012·Archives of Physiology and Biochemistry·Muaz BelviranliSadik Büyükbaş
Jul 14, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Maria KamperElli F Kamper
Aug 12, 2009·Biochimica Et Biophysica Acta·Matthew S Macauley, David J Vocadlo
Aug 4, 2009·Biochimica Et Biophysica Acta·Carlos Martinez-FleitesGideon J Davies
Apr 14, 2009·Free Radical Biology & Medicine·Andreína Peralta-LealF Javier Oliver
Nov 18, 2003·Clinical and Experimental Immunology·M KoulmandaR N Smith
Aug 22, 2008·International Journal of Experimental Pathology·Ana Rosa CunhaCarlos Alberto Mandarim-de-Lacerda
Apr 11, 2008·Scandinavian Journal of Immunology·S HässlerO Winqvist
Aug 26, 2010·Journal of the Science of Food and Agriculture·Yeu-Ching Shi, Tzu-Ming Pan
Feb 17, 2009·Carbohydrate Research·Yuan HeGideon J Davies

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.